ReviewAnalytical and bioanalytical chemistry2025
Quality assurance and quality control for human biomonitoring data-focus on matrix reference materials.
Review in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- Development and certification of SARS-CoV-2 S-RBD protein reference material via dual isotope dilution mass spectrometry.Analytical and bioanalytical chemistry · 2026Article
- Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis.Molecular neurobiology · 2026Review
- Risk Assessment of Chemical Mixtures in Foods: A Comprehensive Methodological and Regulatory Review.Foods (Basel, Switzerland) · 2026Review
- Protective effect ofFrontiers in toxicology · 2026Article
- Human Biomonitoring of Butylated Hydroxytoluene (BHT) in Germany: Methods, Exposure Levels, and Health-Based Interpretation.La Medicina del lavoro · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human biomonitoring (HBM) is an essential tool for making evidence-based policy decisions upon assessment of human exposure to pollutants. In contrast, the heterogeneity of data reliability across studies has been identified as a weakness in current HBM research. The scientific community is currently encountering measurement challenges due to gaps in the availability of quality assurance/quality control (QA/QC) tools. This article provides a summarised view on the availability of reference materials in human matrices such as hair, serum, blood, plasma, urine, and breast milk for selected groups of organic contaminants (e.g., pesticides, flame retardants, perfluorinated compounds, perchlorate, phthalates, phenols) and elements (e.g., mercury, arsenic, cadmium, chromium, lead, nickel, tin) of relevance to human health. The QA/QC situation of HBM measurement data with regard to laboratories' performance in proficiency testing schemes is also addressed, highlighting areas for improvement. Finally, the article uses the example of per- and polyfluoroalkyl substance analysis to illustrate QA/QC challenges specifically related to the HBM field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.